Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.

IF 11.7 1区 医学 Q1 CLINICAL NEUROLOGY
Brain Pub Date : 2025-10-03 DOI:10.1093/brain/awaf179
Chaitali Anand, Farras Abdelnour, Benjamin Sipes, Daren Ma, Pedro D Maia, Justin Torok, Ashish Raj
{"title":"Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.","authors":"Chaitali Anand, Farras Abdelnour, Benjamin Sipes, Daren Ma, Pedro D Maia, Justin Torok, Ashish Raj","doi":"10.1093/brain/awaf179","DOIUrl":null,"url":null,"abstract":"<p><p>Brain regions in Alzheimer's disease exhibit distinct vulnerability to its hallmark pathology with the entorhinal cortex and hippocampus succumbing early to tau tangles while others like the primary sensory cortices remain resilient. The quest to understand how local/regional genetic factors, pathogenesis and network-mediated pathology spread, together govern this selective vulnerability (SV) or resilience (SR) is ongoing. Although many Alzheimer's risk genes are known from gene association and transgenic studies, it is still unclear whether and how their baseline expression confers SV/SR to pathology. Prior analyses have yielded conflicting results, pointing to a disconnect between the location of genetic risk factors and downstream tau pathology. The spatial distribution of vulnerability doesn't always align with genetic factors, suggesting a role for non-cell-autonomous mechanisms like transneuronal tau transmission. We hypothesize that a full accounting of the role of genes in mediating SV/SR would require modelling of network-based vulnerability, whereby tau misfolds, aggregates and propagates along fibre projections. We employed an extended network diffusion model (eNDM) and fitted it on tau PET data from 196 patients from the Alzheimer's Disease Neuroimaging Initiative. The fitted eNDM then becomes a reference from which to assess the role of innate genetic factors. Using the residual (observed - model-predicted) tau as a novel target outcome, we obtained its association with 100 Alzheimer's risk genes, whose baseline spatial transcriptional profiles were obtained from the Allen Human Brain Atlas. Our eNDM was successful in capturing tau pathology distribution in patients. After regressing out the model, we found that while many risk genes have spatial expression patterns that correlate with regional tau, many others showed a stronger association with residual tau. This suggests that direct vulnerability aligned with the network, as well as network-independent vulnerability, are conferred by risk genes. We report four classes of risk genes: network-aligned SV (SV-NA), network-independent SV (SV-NI), network-aligned SR (SR-NA) and network-independent SR (SR-NI), each with a distinct spatial signature and associated vulnerability to tau. Remarkably, using gene ontology analysis, we found that the identified gene classes have distinct and sometimes surprising functional enrichment patterns. Network-aligned genes broadly participate in cell death, stress response and metabolic processing; network-independent genes in amyloid-β processing and immune response. These previously unreported segregated roles point to multiple distinct pathways by which risk genes confer vulnerability or resilience in Alzheimer's disease. Our findings offer new insights into vulnerability signatures in Alzheimer's disease and may prove helpful in identifying potential intervention targets.</p>","PeriodicalId":9063,"journal":{"name":"Brain","volume":" ","pages":"3679-3693"},"PeriodicalIF":11.7000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12493037/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awaf179","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Brain regions in Alzheimer's disease exhibit distinct vulnerability to its hallmark pathology with the entorhinal cortex and hippocampus succumbing early to tau tangles while others like the primary sensory cortices remain resilient. The quest to understand how local/regional genetic factors, pathogenesis and network-mediated pathology spread, together govern this selective vulnerability (SV) or resilience (SR) is ongoing. Although many Alzheimer's risk genes are known from gene association and transgenic studies, it is still unclear whether and how their baseline expression confers SV/SR to pathology. Prior analyses have yielded conflicting results, pointing to a disconnect between the location of genetic risk factors and downstream tau pathology. The spatial distribution of vulnerability doesn't always align with genetic factors, suggesting a role for non-cell-autonomous mechanisms like transneuronal tau transmission. We hypothesize that a full accounting of the role of genes in mediating SV/SR would require modelling of network-based vulnerability, whereby tau misfolds, aggregates and propagates along fibre projections. We employed an extended network diffusion model (eNDM) and fitted it on tau PET data from 196 patients from the Alzheimer's Disease Neuroimaging Initiative. The fitted eNDM then becomes a reference from which to assess the role of innate genetic factors. Using the residual (observed - model-predicted) tau as a novel target outcome, we obtained its association with 100 Alzheimer's risk genes, whose baseline spatial transcriptional profiles were obtained from the Allen Human Brain Atlas. Our eNDM was successful in capturing tau pathology distribution in patients. After regressing out the model, we found that while many risk genes have spatial expression patterns that correlate with regional tau, many others showed a stronger association with residual tau. This suggests that direct vulnerability aligned with the network, as well as network-independent vulnerability, are conferred by risk genes. We report four classes of risk genes: network-aligned SV (SV-NA), network-independent SV (SV-NI), network-aligned SR (SR-NA) and network-independent SR (SR-NI), each with a distinct spatial signature and associated vulnerability to tau. Remarkably, using gene ontology analysis, we found that the identified gene classes have distinct and sometimes surprising functional enrichment patterns. Network-aligned genes broadly participate in cell death, stress response and metabolic processing; network-independent genes in amyloid-β processing and immune response. These previously unreported segregated roles point to multiple distinct pathways by which risk genes confer vulnerability or resilience in Alzheimer's disease. Our findings offer new insights into vulnerability signatures in Alzheimer's disease and may prove helpful in identifying potential intervention targets.

Abstract Image

Abstract Image

Abstract Image

选择性脆弱性和恢复力对阿尔茨海默病的tau病作为基因和连接组的功能。
阿尔茨海默病的大脑区域对其标志病理学表现出明显的脆弱性,内嗅皮层和海马体很早就屈服于tau缠结,而其他区域如初级感觉皮层则保持弹性。了解局部/区域遗传因素、发病机制和网络介导的病理传播如何共同控制这种选择性脆弱性(SV)或恢复力(SR)的探索正在进行中。尽管许多阿尔茨海默病的风险基因已经从基因关联和转基因研究中被发现,但它们的基线表达是否以及如何导致SV/SR病理尚不清楚。先前的分析产生了相互矛盾的结果,指出遗传风险因素的位置与下游tau病理之间存在脱节。脆弱性的空间分布并不总是与遗传因素一致,这表明非细胞自主机制如跨神经元tau传递的作用。我们假设,要全面考虑基因在介导SV/SR中的作用,需要对基于网络的脆弱性进行建模,由此tau蛋白错误折叠、聚集和沿纤维突起传播。我们采用了扩展网络扩散模型(eNDM),并将其拟合到来自阿尔茨海默病神经影像学倡议的196名患者的tau PET数据上。然后,拟合的eNDM成为评估先天遗传因素作用的参考。使用残差(观察-模型-预测)tau作为新的目标结果,我们获得了它与100个阿尔茨海默病风险基因的关联,这些基因的基线空间转录谱来自Allen人脑图谱。我们的eNDM成功地捕获了患者的tau病理分布。在对模型进行回归后,我们发现,虽然许多风险基因具有与区域tau相关的空间表达模式,但许多其他风险基因显示与残留tau有更强的关联。这表明,与网络相关的直接脆弱性以及与网络无关的脆弱性都是由风险基因赋予的。我们报告了四类风险基因:网络相关的SV (SV- na)、网络无关的SV (SV- ni)、网络相关的SR (SR- na)和网络无关的SR (SR- ni),每一类都具有不同的空间特征和相关的tau易感性。值得注意的是,通过基因本体分析,我们发现鉴定的基因类具有不同的,有时令人惊讶的功能富集模式。网络对齐基因广泛参与细胞死亡、应激反应和代谢过程;淀粉样蛋白-β加工和免疫反应中的网络无关基因。这些以前未报道的分离作用指出了多种不同的途径,通过这些途径,风险基因赋予阿尔茨海默病的脆弱性或复原力。我们的发现为阿尔茨海默病的脆弱性特征提供了新的见解,可能有助于确定潜在的干预目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Brain
Brain 医学-临床神经学
CiteScore
20.30
自引率
4.10%
发文量
458
审稿时长
3-6 weeks
期刊介绍: Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信